Budget Amount *help |
¥2,470,000 (Direct Cost: ¥1,900,000、Indirect Cost: ¥570,000)
Fiscal Year 2009: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2008: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
|
Research Abstract |
The progress of the recent molecular target drug is remarkable, and the medicine associated with the growth factor receptor is applied clinically, and those effectiveness is confirmed. Therefore we thought that we could apply these treatment to even relatively developing esophageal cancer in the field of molecular target therapy and aimed at a role of keratinocyte growth factor receptor (KGFR) which played role that was important to proliferation of cells and angiogenesis in esophageal cancer. Progressed a study whether KGFR was associated with a proliferation of esophageal cancer whether we might prevent growth of esophageal cancer by inhibiting KGFR and examined it about the future as the molecular target therapy.
|